ARTIVION, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for ARTIVION, INC. (AORT), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are AORT insiders buying or selling?
ARTIVION, INC. insiders reported 7 open-market buys ($899.5K) and 243 sells ($59.3M) across 250 Form 4 filings — a net selling position of $58.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 15, 2026)
Insider sentiment
Net sellingNet insider flow of $58.4M in net selling.
Recent AORT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Andrew M Green | SVP, Regulatory and Quality | Sale | 44.0K | $20.70 | $910.7K |
| Mar 4, 2026 | Amy Horton | VP, Chief Accounting Officer | Sale | 901 | $37.78 | $34.0K |
| Mar 4, 2026 | Jean F Holloway | SVP, General Counsel | Sale | 12.8K | $37.93 | $485.7K |
| Mar 4, 2026 | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale | 2.1K | $37.78 | $81.2K |
| Mar 4, 2026 | John E Davis | Chief Commercial Officer | Sale | 4.6K | $37.78 | $172.7K |
| Mar 4, 2026 | Lance A Berry | EVP, COO, CFO & Treasurer | Sale | 6.3K | $37.78 | $238.6K |
| Mar 4, 2026 | James P Mackin | President & CEO | Sale | 17.9K | $37.78 | $675.7K |
| Mar 3, 2026 | Amy Horton | VP, Chief Accounting Officer | Sale | 641 | $38.02 | $24.4K |
| Mar 3, 2026 | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale | 1.5K | $38.02 | $57.5K |
| Mar 3, 2026 | James P Mackin | President & CEO | Sale | 14.9K | $38.02 | $567.0K |
| Mar 3, 2026 | Jean F Holloway | SVP, General Counsel | Sale | 2.2K | $38.02 | $83.0K |
| Mar 3, 2026 | Lance A Berry | EVP, COO, CFO & Treasurer | Sale | 5.2K | $38.02 | $196.9K |
| Mar 3, 2026 | John E Davis | Chief Commercial Officer | Sale | 2.8K | $38.02 | $105.9K |
| Feb 25, 2026 | Amy Horton | VP, Chief Accounting Officer | Sale | 2.6K | $36.97 | $94.7K |
| Feb 25, 2026 | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale | 3.7K | $36.94 | $136.0K |
| Feb 25, 2026 | Jean F Holloway | SVP, General Counsel | Sale | 4.7K | $36.92 | $175.3K |
| Feb 25, 2026 | James P Mackin | President & CEO | Sale | 34.9K | $36.83 | $1.3M |
| Feb 25, 2026 | Lance A Berry | EVP, COO, CFO & Treasurer | Sale | 9.5K | $36.69 | $347.3K |
| Feb 25, 2026 | John E Davis | Chief Commercial Officer | Sale | 5.8K | $36.92 | $215.9K |
| Dec 17, 2025 | John E Davis | Chief Commercial Officer | Sale | 5.0K | $45.11 | $225.6K |
| Dec 9, 2025 | Amy Horton | VP, Chief Accounting Officer | Sale | 4.6K | $44.42 | $203.1K |
| Dec 5, 2025 | James P Mackin | President & CEO | Sale | 30.9K | $45.46 | $1.4M |
| Dec 5, 2025 | Jean F Holloway | SVP, General Counsel | Sale | 7.3K | $45.30 | $331.4K |
| Dec 4, 2025 | James P Mackin | President & CEO | Sale | 30.9K | $45.56 | $1.4M |
| Nov 24, 2025 | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale | 47.4K | $45.04 | $2.1M |
Showing the 25 most recent of 250 Form 4 filings for ARTIVION, INC..
Most active AORT insiders
- Jean F Holloway41 filings
- Amy Horton37 filings
- John E Davis31 filings
- James P Mackin29 filings
- Marshall S. Stanton21 filings
Ask anything about AORT insider activity
Use Trabud's AI agent to query ARTIVION, INC.'s Form 4 history in plain English — "Show me AORT CEO purchases this year" or compare it against any other ticker.
Open the AI agentAORT insider trading FAQ
Are ARTIVION, INC. insiders buying or selling?
Across 250 SEC Form 4 filings, ARTIVION, INC. (AORT) insiders reported 7 open-market purchases totaling $899.5K and 243 sales totaling $59.3M. That is a net selling position of $58.4M.
How many insiders trade AORT stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ARTIVION, INC.. The most recent filing was accepted on Jun 15, 2026.
Where does Trabud get AORT insider trading data?
All AORT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.